Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1838
https://www.valueinhealthjournal.com/article/S1098-3015(14)03768-1/fulltext
Title :
Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03768-1&doi=10.1016/j.jval.2014.08.1838
First page :
A558
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1312